Role of platelet-derived growth factor-BB (PDGF-BB) in human pulmonary artery smooth muscle cell proliferation

Journal of Receptors and Signal Transduction

Volumn 34, Issue 4, 2014, Pages 254-260

  Zhao, Yan ^a   Lv, Wentao ^b   Piao, Hongying ^a   Chu, Xiaojie ^a   Wang, Hao ^a  

^a DAQING OILFIELD CO LTD   (China)

^b Daqing Medical College   (China)

Author keywords

JNK; PDGF BB; Proliferation; Pulmonary arterial hypertension

Indexed keywords

CYCLIN A; CYCLIN E; CYCLINE; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN C JUN; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INTRACELLULAR SIGNALING; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PULMONARY ARTERY; PULMONARY HYPERTENSION; SMOOTH MUSCLE FIBER; BIOSYNTHESIS; GENETICS; HYPERTENSION; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL PROLIFERATION; CYCLIN A; CYCLIN E; HUMANS; HYPERTENSION; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCYTES, SMOOTH MUSCLE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-SIS; PULMONARY ARTERY;

EID: 84905189905     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.3109/10799893.2014.908915     Document Type: Article

References (34)

1. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004;351:1425-36.
2. Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 2004;351:1655-65.
3. Pietra GG, Capron F, Stewart S, et al. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 2004;43:25S-32S.
4. Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:13S-24S.
5. Farkas L, Gauldie J, Voelkel NF, Kolb M. Pulmonary hypertension and idiopathic pulmonary fibrosis: A tale of angiogenesis, apoptosis, and growth factors. Am J Respir Cell Mol Biol 2011;45:1-15.
6. Siegbahn A, Johnell M, Nordin A, et al. TF/FVIIa transactivate PDGFRbeta to regulate PDGF-BB-induced chemotaxis in different cell types: Involvement of Src and PLC. Arterioscler Thromb Vasc Biol 2008;28:135-41.
7. Perros F, Montani D, Dorfmuller P, et al. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 2008;178:81-8.
8. Humbert M, Monti G, Fartoukh M, et al. Platelet-derived growth factor expression in primary pulmonary hypertension: Comparison of HIV seropositive and HIV seronegative patients. Eur Respir J 1998;11:554-9.
9. Schermuly RT, Dony E, Ghofrani HA, et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 2005;115:2811-21.
10. Mulder KM. Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev 2000;11:23-35.
11. Yue J, Mulder KM. Activation of the mitogen-activated protein kinase pathway by transforming growth factor-beta. Methods Mol Biol 2000;142:125-31.
12. Xu Q, Liu Y, Gorospe M, et al. Acute hypertension activates mitogen-activated protein kinases in arterial wall. J Clin Invest 1996;97:508-14.
13. Izumi Y, Kim S, Namba M, et al. Gene transfer of dominantnegative mutants of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase prevents neointimal formation in ballooninjured rat artery. Circ Res 2001;88:1120-6.
14. Force T, Pombo CM, Avruch JA, et al. Stress-activated protein kinases in cardiovascular disease. Circ Res 1996;78:947-53.
15. Garat CV, Fankell D, Erickson PF, et al. Platelet-derived growth factor BB induces nuclear export and proteasomal degradation of CREB via phosphatidylinositol 3-kinase/Akt signaling in pulmonary artery smooth muscle cells. Mol Cell Biol 2006;26:4934-48.
16. Das M, Bouchey DM, Moore MJ, et al. Hypoxia-induced proliferative response of vascular adventitial fibroblasts is dependent on g protein-mediated activation of mitogen-activated protein kinases. J Biol Chem 2001;276:15631-40.
17. Short M, Nemenoff RA, Zawada WM, et al. Hypoxia induces differentiation of pulmonary artery adventitial fibroblasts into myofibroblasts. Am J Physiol Cell Physiol 2004;286:C416-25.
18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem 1976;72:248-54.
19. Medhora M, Chen Y, Gruenloh S, et al. 20-HETE increases superoxide production and activates NAPDH oxidase in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 2008; 294:L902-11.
20. Nakano H, Namatame K, Nakayoshi A, Kumada K. [The evaluation of cellular proliferating activity in gastric carcinoma with the proliferating cell nuclear antigen expressive rate: Its fundamental examination of the immunohistochemical procedures and its clinical applications]. Nihon Geka Gakkai Zasshi 1993;94:580-92.
21. Paterlini P, Suberville AM, Zindy F, et al. Cyclin A expression in human hematological malignancies: A new marker of cell proliferation. Cancer Res 1993;53:235-8.
22. Girard F, Strausfeld U, Fernandez A, Lamb NJ. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 1991;67:1169-79.
23. Knoblich JA, Sauer K, Jones L, et al. Cyclin E controls S phase progression and its down-regulation during Drosophila embryogenesis is required for the arrest of cell proliferation. Cell 1994;77: 107-20.
24. Jurek A, Heldin CH, Lennartsson J. Platelet-derived growth factorinduced signaling pathways interconnect to regulate the temporal pattern of Erk1/2 phosphorylation. Cell Signal 2011;23:280-7.
25. Welsh DJ, Peacock AJ, MacLean M, Harnett M. Chronic hypoxia induces constitutive p38 mitogen-activated protein kinase activity that correlates with enhanced cellular proliferation in fibroblasts from rat pulmonary but not systemic arteries. Am J Respir Crit Care Med 2001;164:282-9.
26. Welsh DJ, Scott PH, Peacock AJ. p38 MAP kinase isoform activity and cell cycle regulators in the proliferative response of pulmonary and systemic artery fibroblasts to acute hypoxia. Pulm Pharmacol Ther 2006;19:128-38.
27. Sabapathy K, Hochedlinger K, Nam SY, et al. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol Cell 2004;15:713-25.
28. Salido M, Gonzalez JL, Vilches J. Loss of mitochondrial membrane potential is inhibited by bombesin in etoposide-induced apoptosis in PC-3 prostate carcinoma cells. Mol Cancer Ther 2007;6:1292-9.
29. Mathur A, Hong Y, Kemp BK, et al. Evaluation of fluorescent dyes for the detection of mitochondrial membrane potential changes in cultured cardiomyocytes. Cardiovasc Res 2000;46:126-38.
30. Castedo M, Ferri K, Roumier T, et al. Quantitation of mitochondrial alterations associated with apoptosis. J Immunol Methods 2002; 265:39-47.
31. Stenmark KR, Mecham RP. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol 1997;59: 89-144.
32. Voelkel NF, Tuder RM. Cellular and molecular biology of vascular smooth muscle cells in pulmonary hypertension. Pulm Pharmacol Ther 1997;10:231-41.
33. Ghofrani HA, Seeger W, Grimminger F. Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med 2005;353: 1412-13.
34. Kerkela R, Grazette L, Yacobi R, et al. Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat Med 2006;12:908-16.